Clinical Trial Update: Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for avelumab in MSI-H or POLE-mutated metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Asan Medical Center | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN